0 Recommendations
Does anyone know if there is an ovarian cancer pill out there yet?
Already a member? Sign in
Welcome to Inspire!
What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.
Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.
How - Joining Inspire is completely free and usually takes less than a minute. Join now!
Ovarian Cancer
- By celestdragon
- Posted July 11, 2009 at 5:08 pm · 5 replies
- In Clinical trials
- Shared with the public
Explore topics in this discussion:
Targeted therapy Cancer Thalidomide Breast cancer Ovarian cancer
5 replies
- Oldest first
- Newest first
- By zircons
- Posted July 12, 2009 at 3:41 pm
- Report post
Do you mean a pill to cure ovarian cancer? If yes, no there is not. If there was one, we would all be on it. I am beginning a new clinical study next week that consists of carbo, gemzar and a new pill. It has stopped lymphoma, but has not be used yet for ovarian cancer.
- By Jennali
- Posted July 12, 2009 at 8:12 pm
- Report post
Some chemo drugs come in pill form. There are other drugs, such as Thalidomide, which are pills sometimes given in conjunction with chemo to boost its effect.
- By cdbart
- Posted July 13, 2009 at 4:47 pm
- Report post
There is also a new trial that is using chem in a pil form.
- By celestdragon
- Posted July 14, 2009 at 10:51 pm
- Report post
Thanks for responding. I just got some info from my doctor, and a new pill is coming out in a few months. Here's an article about it!
Now a breakthrough discovery in the United Kingdom may one day be just what the doctor ordered for women with BRCA1 and/or BRCA2 mutations: PARP inhibitors, targeted therapy using enzymes that appear to destroy hereditary breast cancer tumors without harming normal cells.
PARP inhibitors work by selectively killing cells which have no functioning BRCA gene, preventing cells from using their backup repair mechanism. Healthy cells which retain their DNA repair capability theoretically would remain unharmed. Preliminary experiments with mice have been encouraging, killing breast cancer cells that lack BRCA function and eliminating tumors. “If our laboratory findings are confirmed in the clinic, we could dramatically improve the treatment of patients with BRCA1 or 2 associated cancers,” says Dr. Andrew Tutt, a key researcher.
the first steps in the developmental timeline involving humans are Phase I studies; small trials of PARP inhibitors (consisting of 40 participants) are beginning in the United Kingdom to monitor the medication’s safety and establish appropriate oral patient doses. If successful, larger clinical trials with BRCA patients will follow. Under the best circumstances, funding trials of targeted therapies and finding qualified participants often requires organized, concerted efforts by patient advocacy groups. Meanwhile, we must continue to unite our community and advocate for our population.
- By celestdragon
- Posted July 14, 2009 at 10:52 pm
- Report post
Here's the website to go to:
http://www.msnbc.msn.com/id/31512315/ns/health-womens_health/
Add to the discussion